Followers | 473 |
Posts | 30113 |
Boards Moderated | 1 |
Alias Born | 11/12/2016 |
Wednesday, July 24, 2024 9:13:45 AM
Recent MGRX News
- MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions • GlobeNewswire Inc. • 10/03/2024 12:30:00 PM
- Healthcare Shares Rise Following Product Availability Announcement • AllPennyStocks.com • 10/01/2024 05:05:00 PM
- MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment • GlobeNewswire Inc. • 10/01/2024 11:30:00 AM
- MangoRx Reports 1,685% Increase in Shareholders’ Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024 • GlobeNewswire Inc. • 08/15/2024 01:25:00 PM
- MangoRx Receives Certificate of Grant in India for its Respiratory Illness and Preventive Care Technology Patent • GlobeNewswire Inc. • 08/13/2024 08:00:00 PM
- MangoRx Completes Migration to DEA-Approved Telemedicine Platform, Accelerating Timeline of Oral Dissolvable GLP-1 Weight Loss Treatments Featuring Semaglutide and Tirzepatide • GlobeNewswire Inc. • 08/09/2024 12:15:00 PM
- MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention Technology • GlobeNewswire Inc. • 07/24/2024 12:15:00 PM
- Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access • GlobeNewswire Inc. • 07/18/2024 08:05:00 PM
- MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts • GlobeNewswire Inc. • 07/16/2024 12:20:00 PM
- MangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation Department • GlobeNewswire Inc. • 07/12/2024 05:30:00 PM
- MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets • GlobeNewswire Inc. • 07/11/2024 12:15:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/18/2024 06:57:05 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/10/2024 05:28:45 PM
- MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology • GlobeNewswire Inc. • 06/06/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 09:15:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 09:15:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 09:15:24 PM
- MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont Technologies • GlobeNewswire Inc. • 06/04/2024 08:00:00 PM
- MangoRx to Introduce “MOJO” Pharmaceutical Compounded Formula Featuring Enclomiphene Citrate and Pregnenolone for Treatment of Low Testosterone and Male Hormone Imbalances • GlobeNewswire Inc. • 06/04/2024 12:00:00 PM
- Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Distribution in Mexico and Latin American Markets • GlobeNewswire Inc. • 05/28/2024 12:30:00 PM
- MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts • GlobeNewswire Inc. • 05/23/2024 12:30:00 PM
- MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications • GlobeNewswire Inc. • 05/21/2024 12:30:00 PM
- MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market Penetration • GlobeNewswire Inc. • 05/16/2024 08:40:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 05/16/2024 05:59:25 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/16/2024 01:19:29 PM
FEATURED Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM
BNCM COMPLETES MERGER WITH DELEX HEALTHCARE • BNCM • Oct 8, 2024 9:54 AM
CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024 • CBDL • Oct 8, 2024 8:00 AM
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM